苯拉唑马布
医学
慢性阻塞性肺病
肺病
内科学
单克隆抗体
单克隆
重症监护医学
免疫学
抗体
哮喘
嗜酸性粒细胞
美波利祖马布
作者
Gerard J. Criner,Bartolomé R. Celli,Christopher E. Brightling,Àlvar Agustí,Alberto Papi,Dave Singh,Don D. Sin,Claus Vogelmeier,Frank C. Sciurba,Mona Bafadhel,Vibeke Backer,Motokazu Kato,Alejandra Ramírez‐Venegas,Yu-Feng Wei,Leif Bjermer,Vivian H. Shih,Maria Jison,Sean O’Quinn,Natalya Makulova,Paul Newbold
标识
DOI：10.1056/nejmoa1905248
摘要
The efficacy and safety of benralizumab, an interleukin-5 receptor alpha–directed cytolytic monoclonal antibody, for the prevention of exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) are not known.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
SYLH
爱静静
昏睡的蟠桃
FIN
1351567822
eric888
海东来
fang
ED
GingerF
七月流火
aldehyde
Rondab
yx_cheng
彭于彦祖
比比谁的速度快
Singularity
yydragen
deallyxyz
nanaki
皖公网安备34019202002308
